BRCA1 and cancer: Professionals must be knowledgeable about the range of genetic susceptibility variants relevant to the particular cancer including variants with low (e.g., SNPs), intermediate (e.g., CHEK2 mutations) or higher predictive value (such as BRCA1/2 mutations) and the significance that these may have for the individual and their family members.